Lithium

Lithium

SCHEMBL8712004

CCOP(=O)(OCC)C(O)(Cc1cccnc1)S(=O)(=O)O.[Li]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FDPS P14324 7/20 0.49
BTN3A1 O00481 1/20 0.49
PDE3A Q14432 1/20 0.49
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
MMP1 P03956 2/20 0.38
MMP13 P45452 2/20 0.38
MMP9 P14780 1/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
PKM P14618 1/20 0.37
KMT2A Q03164 1/20 0.37
ADAM17 P78536 1/20 0.37
RIPK1 Q13546 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8711994 0.98 FDPS (0.49) FDPSBTN3A1PDE3ACYP1A2CYP3A4
Lithium Ion SCHEMBL8711998 0.87 FDPS (0.48) FDPSBTN3A1PDE3ACYP1A2CYP3A4
SCHEMBL8711909 0.80 FDPS (0.66) FDPSBTN3A1PDE3ACYP1A2CYP3A4
SCHEMBL8712269 0.77 FDPS (0.49) FDPSBTN3A1PDE3ACYP1A2CYP3A4
SCHEMBL8159960 0.76 FDPS (0.67) FDPSBTN3A1PDE3ACYP1A2CYP3A4
SCHEMBL7853031 0.71 FDPS (0.54) FDPSBTN3A1PDE3ACYP1A2CYP3A4
SCHEMBL9225849 0.71 KCNA5 (0.35) FDPSBTN3A1PDE3ACYP1A2CYP3A4
SCHEMBL8712326 0.69 FDPS (0.48) FDPSBTN3A1PDE3ALMNAMAPK1
SCHEMBL578225 0.68 FDPS (0.45) FDPSBTN3A1PDE3ALMNAMAPK1
SCHEMBL23637410 0.68 FDPS (0.56) FDPSBTN3A1PDE3ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0642518-B1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMA (US) 1998-08-05 EP disclosed
US-5731299-A OSTEOPOROSIS; RHEUMATOID ARTHRITIS THE PROCTER & GAMBLE COMPANY (US) 1998-03-24 US disclosed
EP-0642518-A1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS (US) 1995-03-15 EP disclosed
WO-1993024495-A1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1993-12-09 WO disclosed